Deutsche Bank’s Instil Bio TIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-310
Closed -$2.67K 3702
2023
Q3
$2.67K Sell
310
-498
-62% -$5.02K ﹤0.01% 3633
2023
Q2
$8.91K Sell
808
-2,873
-78% -$35.1K ﹤0.01% 3657
2023
Q1
$48.7K Buy
3,681
+2,072
+129% +$30.6K ﹤0.01% 3553
2022
Q4
$20.3K Sell
1,609
-772
-32% -$38.2K ﹤0.01% 3768
2022
Q3
$231K Buy
2,381
+736
+45% +$84.2K ﹤0.01% 2866
2022
Q2
$152K Buy
1,645
+133
+9% +$18.8K ﹤0.01% 3319
2022
Q1
$325K Sell
1,512
-174
-10% -$40.7K ﹤0.01% 3003
2021
Q4
$577K Buy
1,686
+1,173
+229% +$453K ﹤0.01% 2747
2021
Q3
$183K Sell
513
-4
-0.8% -$1.49K ﹤0.01% 3609
2021
Q2
$200K Buy
+517
New +$192K ﹤0.01% 3794

Other funds holding TIL

Deutsche Bank's TIL Position: Q4 2023 in Review

Deutsche Bank sold out of Instil Bio (TIL) in Q4 2023, closing a stake of 310 shares — an estimated $2.67K sold.

Deutsche Bank first reported a position in TIL in Q2 2021 and held it in 10 quarters. The position peaked at $577K in Q4 2021. 30 funds tracked by Wall St. Rank hold TIL as of Q4 2023.

  • Deutsche Bank reported no remaining Instil Bio position as of Q4 2023 after selling out during the quarter.
  • Deutsche Bank sold 310 Instil Bio shares in Q4 2023, an estimated $2.67K.
  • Deutsche Bank first reported a position in Instil Bio in Q2 2021 and held it in 10 quarters.
  • Deutsche Bank's Instil Bio position peaked at $577K in Q4 2021.
  • 30 funds tracked by Wall St. Rank held Instil Bio as of Q4 2023.

Based on Deutsche Bank's 13F filing for Q4 2023, filed 14 Feb 2024.